4//SEC Filing
Reich Samuel J 4
Accession 0001209191-22-050106
CIK 0001833214other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 5:15 PM ET
Size
5.7 KB
Accession
0001209191-22-050106
Insider Transaction Report
Form 4
Reich Samuel J
DirectorCEO & EXECUTIVE CHAIRMAN
Transactions
- Award
Employee Stock Option (right to buy)
2022-09-13+525,000→ 525,000 totalExercise: $0.71Exp: 2032-09-13→ Common Stock (525,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
- [F2]The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001394645
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 5:15 PM ET
- Size
- 5.7 KB